<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Data Management, Semantics and Personal Health Apps for Staying Safe in COVID-19 1</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><forename type="first">Dimitrios</forename><forename type="middle">G</forename><surname>Katehakis</surname></persName>
							<email>katehaki@ics.forth.gr</email>
						</author>
						<author>
							<persName><forename type="first">Angelina</forename><surname>Kouroubali</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Georgios</forename><surname>Kavlentakis</surname></persName>
						</author>
						<author>
							<affiliation key="aff0">
								<orgName type="department">Fokion Logothetidis</orgName>
								<orgName type="institution">Nikos Stathiakis</orgName>
								<address>
									<settlement>Yannis Petrakis</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff1">
								<orgName type="department">Stavros Kostomanolakis</orgName>
								<orgName type="institution" key="instit1">Vassilis Tzikoulis</orgName>
								<orgName type="institution" key="instit2">Haridimos Kondylakis Institute of Computer Science</orgName>
								<orgName type="institution" key="instit3">FORTH</orgName>
								<address>
									<settlement>Heraklion</settlement>
									<country key="GR">Greece</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Data Management, Semantics and Personal Health Apps for Staying Safe in COVID-19 1</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">029598066A9490E8B0C037F668406F49</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2" ident="GROBID" when="2023-03-24T21:37+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>The ongoing coronavirus pandemic, is affecting the lives of millions of people, while changing our society by establishing new norms for social life, business, and traveling. The digital health domain has already tried to respond to the pandemic challenges, by the rapid development and release of mobile apps aiming to "flatten the curve" of the increasing number of COVID-19 cases. In this paper, starting from our own developed app to support citizens staying "Safe in COVID-19", we present our vision on how semantics and data management could highly contribute, along with personal health apps, to the secondary usage of available data in order to support effective disease management, prediction and increase the collective knowledge on the disease.</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p>The coronavirus disease 2019 (COVID- <ref type="bibr" target="#b16">19</ref>) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) <ref type="bibr" target="#b0">[1]</ref>. Governments worldwide, in order to address the ongoing pandemic of COVID-19, have taken confinement measures that have resulted in an unprecedented disruption of lives and work for millions of people <ref type="bibr" target="#b1">[2]</ref>. Measures have focused on the reduction of the spread of the epidemic and the minimization of the load of morbidity and mortality so that health care systems remain functional <ref type="bibr" target="#b2">[3]</ref>.</p><p>Key control measures include contact tracing, followed by treatment or isolation. For symptomatic patients, the following minimum set of data needs to be collected that includes information about date of symptom onset, referral criteria (based on clinical severity and presence of vulnerability factors), contact isolation status (at home, at the hospital, or at other self-isolation facility), and whether a sample has been taken (date of collection). The monitoring phase ends 14 days after the contact's last exposure to a new case, or if the contact develops COVID-19. In the latter case, monitoring is ex-tended, not only for medical purposes but also for public health purposes so that isolation status is properly maintained, test results are directly shared with interested parties, and social patterns are analyzed.</p><p>However, patient data when available are not in the appropriate structure or form to be readily used by health applications available to citizens and health care providers. Real-time relevant health data is not even available to citizens to help them make basic decisions, such as going to a healthcare provider or going to work, etc. Healthcare professionals want to know how their patients' health is evolving in real time. Decision makers are not able to monitor citizens who report relevant symptoms and have not been tested with a diagnostic test for COVID-19 as well as how these cases evolve.</p><p>In response to the need to rapidly perform contact monitoring, many digital tools have been developed to assist with contact tracing and case identification <ref type="bibr" target="#b3">[4]</ref>. Despite the fact that it is mobile solutions that enable the automatic detection of contacts, saving precious hours of work of public health staff, still several concerns have been raised from the very beginning in regards to legal and technical safeguards <ref type="bibr" target="#b4">[5]</ref>.</p><p>Non-functional specifications essential for the delivery of trustworthy apps are relevant to compliance with GDPR provisions, role-based access to patient depending on end-user roles, ensuring accuracy and security of the data, the ability to communicate with other applications/ registries using international standards (e.g. COVID-19 registries, citizen and healthcare professional identification service, etc.), as well as compliance with approved medical protocols.</p><p>To tackle these problems a solution named "Safe in COVID-19" has been developed, already published in <ref type="bibr" target="#b5">[6]</ref>, and is based upon existing work on personal health record systems <ref type="bibr" target="#b6">[7,</ref><ref type="bibr" target="#b7">8,</ref><ref type="bibr" target="#b8">9]</ref> and the development of integrated care solutions to effectively support personal health management and public health <ref type="bibr" target="#b9">[10]</ref>.</p><p>This paper presents our vision of how digital technologies can help governments address epidemics such as COVID-19. It elaborates on the requirements necessary so that digital platforms can act as outbreak response tools. These include appropriate and effective data management and semantics as well as personal health apps that address the needs of citizens to effectively support contact tracing while staying safe in COVID-19. In addition, we highlight the existing technological, political and social barriers that need to be overcome for the effective digital management of the pandemic.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2">Relevant Work</head><p>Mobile technology has been leveraged in a number of ways to control the spread of COVID-19. During the past few months, mobile applications have been widely developed to facilitate self-assessment at home, training, information sharing, contact tracing, and decision making, swiftly offering effective and usable tools against the COVID-19 pandemic <ref type="bibr" target="#b10">[11]</ref>. Platforms like COVIDSafe in Australia [12] for example, offer the ability to document registered isolation, to create a safeguard for isolated individuals, and to allow public health to conduct appropriate analysis and research. COVID Symptom Tracker <ref type="bibr" target="#b11">[13]</ref> developed in the US, helps track the onset and progression of symptoms with the goal of shedding light on the nature of the disease, to identify those at risk sooner, to pinpoint virus hot spots and to help slow the spread of the disease. The Global Outbreak Alert and Response Network (GOARN) has developed Go.Data, a software application specifically designed to manage case-contact relationships and the follow-up of contacts <ref type="bibr">[14]</ref>. Go.data has been deployed to over 35 countries in support of the COVID-19 Pandemic response. Several countries, such as France, Croatia, Germany, and Norway have already developed e-government apps for their citizens, under the direction or with the endorsement of public organizations.</p><p>Technical and privacy issues have been the main reasons for the slow adoption of digital solutions, despite the fact that some concerns have been addressed. In addition, it has been evident in the past few months that location tracking isn't popular. Unfortunately, evidence based assessment of existing apps is still not existent <ref type="bibr" target="#b10">[11]</ref>. In addition, most solutions do not comprehensively include a full range of features. An important need includes the development and utilization of decision support tools to assist policy optimization for minimizing negative socio-economic impact, while contributing to the containment of the pandemic. Furthermore, despite the fact that online analytic dashboards for tracking COVID-19 exist <ref type="bibr" target="#b12">[15]</ref>, currently they present mostly recovered, and confirmed cases and deaths, and although massive numbers of data are collected, they exist in isolated data islands that are not widely available and hence cannot be used to enable further statistical analysis and prediction making.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3">Digital Platforms as Outbreak Response Tools</head><p>Mobile apps mostly providing location tracking, are not popular due to the many protocols currently available and their fragmented adoption. However, for such an app to be useful, to begin with, we envision an interoperability layer to be available, enabling the various such solutions to exchange data, providing a unifying layer on top of the individual proposed solutions.</p><p>To this direction data FAIRification is essential. All collected data should be made immediately findable and accessible through fully anonymization and publishing on the web using digital object identifiers (DOIs) and other permanent identifiers. Relevant ontologies and approaches such as the MHA Semantic Core Ontology <ref type="bibr" target="#b13">[16,</ref><ref type="bibr" target="#b14">17]</ref> can be used for semantically uplifting through mapping <ref type="bibr" target="#b15">[18,</ref><ref type="bibr" target="#b16">19]</ref> and/ or annotating available data using ontology terms. This will allow their rapid re-use, enabling a common understanding of the available data and offering a rich set of terms for documenting and adding meta-data to the data provided by the platform.</p><p>For enabling interoperability <ref type="bibr" target="#b17">[20]</ref>, Fast healthcare interoperability resources (FHIR) should be used for the representation of the medical data related to COVID-19 <ref type="bibr" target="#b18">[21]</ref>. There are already established COVID-19 Patient Reported Outcome Observations <ref type="bibr" target="#b19">[22]</ref>, that includes the following symptoms: cough, fatigue, pain in throat, dyspnea, headache, diarrhea, nausea, loss of sense of smell, and temperature. FHIR resources (i.e. Problem and Condition resources) are also appropriate for representation of the underlying diseases related to COVID-19. These resources can automatically be published (properly anonymized) through a FHIR Server, further enabling interoperability with existing hospital health systems. The web app for public health authorities and healthcare professionals will consume these data and present to the end user of each application. The citizen's app can also act as a consumer of the FHIR server, in order to retrieve the personalized recommendations <ref type="bibr" target="#b20">[23,</ref><ref type="bibr" target="#b21">24]</ref> that healthcare professionals published to the FHIR server through the healthcare professional web app. Any hospital information system may also act as a data source for our FHIR architecture, since they can publish patient laboratory results for COVID-19 tests into the FHIR Server. Available applications then will be able retrieve the test results from the FHIR server and present them to the end users.</p><p>In addition, currently the decision support tools available, are limited to dashboards mostly for recovered and confirmed cases and deaths. However, more intelligent dashboards required, enabling the multidimensional exploration of the available data, which will also take into consideration artificial intelligence (AI) algorithms and epidemiological models to make on how the virus is spreading in each geographic region, combining regional, country and health-system data. Instead of raw data AI could work directly on semantically uplifted data, exploiting the semantic correlation in the available data. Being able to predict a few days in advance the number of beds needed is essential for health organizations to have time to organize resources to meet the health needs of their reference population (outsourcing of services, staffing, hotel sanitation, purchase of respirators, etc.).</p><p>It is obvious, that putting such a tool in operation requires close cooperation with public authorities for the development and deployment of the solution at a national level, compliance with approved medical protocols, interoperability with national registries for citizen identification and COVID-19, quality assurance, and the existence of the appropriate legal framework.</p><p>As already described, trust, along with privacy and interoperability, is a key concern for individuals considering the adoption of personal health systems. As data are expected to be directly shared upon their creation appropriate anonymization techniques should be enforced for sharing information among patients, and their relatives, doctors researchers, policy makers and governments.</p><p>To this direction appropriate explanations should be provided to the citizens, encouraging them to use the COVID-19 apps, highlighting their importance for "flattening the curve" and explaining all measures taken to ensure anonymity and confidentiality.</p><p>Actual outcomes of relevant applications to a large extend depend on their ability to integrate with other healthcare services and infrastructure. Characteristics that increase their public value go beyond the focus on efficiency and effectiveness to encompass a wider range of characteristics such as the provision of legitimate user orientation, high level of participation, legality, and equity.</p><p>Safe in COVID-19 digital platform intends to respond to the challenges presented so far by being based on an extensible architecture, focused on all involved stakeholders including citizens and their families, healthcare professionals and public authorities. The platform addresses user information and communication needs and our vision is through semantic and big data technologies to enable, decision support tools on the collected data, and activates the appropriate proximity tracking protocols when needed. Further details are provided in the next section.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Safe in COVID-19</head><p>Safe in COVID-19 is an expandable digital platform that was developed in an effort to support national authorities in Greece. The platform provides tools for:  Public Authorities to have a better overview of the actual situation regarding the existence of suspect, probable and confirmed COVID-19 cases by presenting realtime statistics.  Healthcare professionals to manage and communicate with patients providing medical advice based on their patients reported status.  Citizens and their families to record data on symptoms related to COVID-19, carry out self-assessment of their health condition as well as have access to credible, personalized information/ instructions provided by healthcare professionals. In order to activate the app for a citizen, the user needs to be a confirmed COVID-19 case. Upon activation, the patient can record his/ her daily health and communicate with healthcare professionals if needed. The contacts traced can also have the app activated for them to monitor the progress of their own health and to support better disease control.</p><p>The information that the contact tracing teams gather on each contact are recorded into an internal database and can be pushed into external registries such as the COVID-19 patient registry provided by the national authorities. The platform architecture is shown in Fig. <ref type="figure" target="#fig_0">1</ref> (grey part) and consists of the Application Tier providing the front-end applications to the end-users, and the Business Logic Tier offering the intelligent functionality. All these layers are supported by security and integrity services as described below.</p><p>Application Tier. The Safe in COVID-19 solution includes the following applications: a) A web application for public health authorities; b) a web application for healthcare professionals and c) a mobile application (Android/ iOS) for citizens.</p><p>The web app for public health authorities aims to give a complete picture of the status regarding the spread of the disease at a national level and the measures taken by healthcare services. Real-time detailed data for the suspected, probable and confirmed cases are presented that can be useful for the surveillance of confirmed COVID-19 cases.</p><p>The web app for healthcare providers supports online communication with registered patients in order to provide personalized information and coaching and instant The mobile application for citizens supports, among other things, the ability to record on a daily basis their health status and communicate synchronously or asynchronously with healthcare professionals in order to receive personalized instructions for managing their health. Initially, the patient registers into the platform and provides an initial selfassessment based on a questionnaire for underlying diseases related to COVID-19 (chronic lung disease, severe heart disease, immunosuppression, diabetes, renal failure, liver failure and morbid obesity). On a daily basis, the patient is prompted to record his/her symptoms which are related to COVID-19 and further self-assessment information using a Visual Analog Scale (VAS). These include cough, sore throat, shortness of breath or difficulty of breathing, fatigue, muscle pain, headache, runny nose or nasal congestion, diarrhea, loss of taste or smell. The patient also records vital parameters related to COVID-19 (body temperature, oxygen saturation SPO2, breathing rate, systolic and diastolic blood pressure and heart beats). Reminders for monitoring symptoms and vital parameters based on medical history and symptomatology help patients to proper use the app. The app also facilitates patient access to laboratory tests results.</p><p>Business Logic Tier. This tier consists of middleware services necessary for enabling communication between healthcare professionals and citizens, symptom tracking, managing personalized information and user profiles, general information, personal health records, position tracing, and recommendations. As the Safe in COVID-19 framework is based and significantly extends a fully-fledged PHR system, state of the art communication, user profiling and personal health records come out of the box, whereas the specific COVID symptom monitoring and recommendations along with the position tracking have been implemented specifically for addressing the COVID -19 outbreak. All the services communicate with an internal database to retrieve, update and store data, which are further visualized and presented to the user.</p><p>Security and Integrity. The sensitive nature of healthcare information creates unique security and privacy challenges <ref type="bibr" target="#b22">[25]</ref>. Safe in COVID-19 modules do not process patient identification data but only the unique code generated pseudo-randomly by the health authority to confirm COVID-19 cases. The data processed have been minimized and encrypted in order to enhance security and privacy. Secure coding principles have been applied and all network communications between the modules are encrypted. In addition, the Safe in COVID-19 app for the citizens is consent-based <ref type="bibr" target="#b23">[26]</ref> with full information of intended processing of data. In order to avoid trolling (i.e. entering on purpose false positives, undermining this way faith in the system) users may need to receive appropriate codes when entering data into the app to be confirmed by the server. Position tracking is legitimized by relying on a voluntary adoption by the users for each of the intended purposes.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5">Discussion &amp; Conclusion</head><p>This paper presented the overall requirements that are essential in order to develop digital platforms that can act as disease outbreak support tools. Based on this vision, the digital platform Safe in COVID-19 has been presented, as an example of such a tool for public health authorities, healthcare professionals and citizens.</p><p>Foreseen benefits for public health authorities include decongestion of healthcare units, provision of real-time information on the evolution of suspected, candidate and confirmed cases, online monitoring of the spread of the virus, and effective decisionmaking regarding required measures. Benefits for citizens include systematic recording of symptoms, self-assessment, access to personalized information, and instructions and reminders based on their overall health status. Benefits to healthcare professionals include support in managing patients, reduced time for direct contact with patients, more efficient case management, and improved working conditions.</p><p>The effectiveness of such a digital platform depends on several, interrelated factors: (i) a comprehensive national epidemiologic strategy articulating instrumental support to the public health system (ii) the model selected (architectural, technological, etc.); and (iii) widespread connection with mobile devices.</p><p>Applications such as Safe in COVID-19 bear the potential of providing multiple benefits for the users if governed appropriately. The underlying infrastructure required in order to operate efficiently at a regional or national level is significant, bearing in mind the number of potential links to medical and diagnostic centers around the country and the size of the population under consideration. This of course should be linked to relevant national eHealth initiatives, if it is to be properly scaled up at a national level, in parallel with other means available. The solution supports the return to the "new normal" with less stress and more security for individuals, more direct and safer management of patients by physicians, and better possibilities for monitoring the epidemic by public health authorities. Finally, lessons learned from this experience that could be helpful for the future. Even if the COVID-19 emergency will end soon, such apps will help us to be better prepared in the future.</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig. 1 .</head><label>1</label><figDesc>Fig. 1. Existing (gray) and envisoned (yellow) architectural components.</figDesc></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="1" xml:id="foot_0">"Copyright ©</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="2020" xml:id="foot_1">for this paper by its authors. Use permitted under Creative Commons License Attribution 4.0 International (CC BY 4.0)."</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgement</head><p>Work presented in the paper was supported by the Center for eHealth Applications and Services, Institute of Computer Science, Foundation for Research and Technology -Hellas.</p></div>
			</div>

			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and corona virus disease-2019 (COVID-19): the epidemic and the challenges</title>
		<author>
			<persName><forename type="first">L</forename><surname>Chih-Cheng</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">International journal of antimicrobial agents</title>
		<imprint>
			<biblScope unit="page">105924</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Effects of COVID 19 pandemic in daily life</title>
		<author>
			<persName><forename type="first">A</forename><surname>Haleem</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Javaid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Vaishya</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Med Res Pract</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="78" to="79" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Global Preparedness Against COVID-19: We Must Leverage the Power of Digital Health</title>
		<author>
			<persName><forename type="first">S</forename><surname>Mahmood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Hasan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Carras</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Labrique</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">JMIR Public Health and Surveillance</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">e18980</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<monogr>
		<idno>WHO/2019-nCoV/</idno>
		<ptr target="Contact_Tracing/Tools_Annex/" />
		<title level="m">World Health Organization: Digital tools for COVID-19, Annex: contact tracing in the context of COVID-19</title>
				<imprint>
			<date type="published" when="2020">2020</date>
			<biblScope unit="volume">1</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<monogr>
		<author>
			<persName><forename type="first">A</forename><surname>Pierucci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Walter</surname></persName>
		</author>
		<ptr target="https://rm.coe.int/covid19-joint-statement-28-april/16809e3fd7" />
		<title level="m">Joint Statement on Digital Contact Tracing</title>
				<imprint>
			<date type="published" when="2020-04-28">2020 April 28) (accessed September, 2020</date>
		</imprint>
		<respStmt>
			<orgName>Council of Europe</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<monogr>
		<title level="m" type="main">An eHealth platform for the holistic management of COVID-19</title>
		<author>
			<persName><forename type="first">A</forename><surname>Kouroubali</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2020">2020</date>
			<publisher>Studies in Health Technology and Informatics</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Integrated Care Solutions for the Citizen: Personal Health Record Functional Models to support Interoperability</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Katehakis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">EJBI</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="51" to="58" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">An Integrated Approach Towards Developing Quality Mobile Health Apps for Cancer</title>
		<author>
			<persName><forename type="first">A</forename><surname>Kouroubali</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Koumakis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kondylakis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Katehakis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Mobile Health Applications for Quality Healthcare Delivery</title>
				<imprint>
			<publisher>IGI Global</publisher>
			<date type="published" when="2019">2019</date>
			<biblScope unit="page" from="46" to="71" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Features, outcomes, and challenges in mobile health interventions for patients living with chronic diseases: A review of systematic reviews</title>
		<author>
			<persName><forename type="first">A</forename><surname>Triantafyllidis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">International Journal of Medical Informatics</title>
		<imprint>
			<biblScope unit="volume">132</biblScope>
			<biblScope unit="page">103984</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<monogr>
		<title level="m" type="main">Personal Health ICT Systems to Support Integrated Care Solutions</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Katehakis</surname></persName>
		</author>
		<idno>ICS-FORTH/472</idno>
		<imprint>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="report_type">Technical Report</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">COVID-19 Mobile Apps: A Systematic Review of the Literature</title>
		<author>
			<persName><forename type="first">H</forename><surname>Kondylakis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Katehakis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kouroubali</surname></persName>
		</author>
		<idno>/08/2020:23170</idno>
	</analytic>
	<monogr>
		<title level="j">JMIR Preprints</title>
		<imprint>
			<biblScope unit="volume">03</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<monogr>
		<ptr target="https://covid.joinzoe.com/us" />
		<title level="m">COVID Symptom Tracker</title>
				<imprint>
			<date type="published" when="2020-09">September 2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<monogr>
		<author>
			<persName><forename type="first">R</forename><surname>Zimmermann</surname></persName>
		</author>
		<ptr target="https://app.de-veloper.here.com/coronavirus/" />
		<title level="m">Tracking Coronavirus COVID-19</title>
				<imprint>
			<date type="published" when="2020-09">September 2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Digital patient: Personalized and translational data management through the MyHealthAvatar EU project</title>
		<author>
			<persName><forename type="first">H</forename><surname>Kondylakis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">IEEE EMBC</title>
		<imprint>
			<biblScope unit="page" from="1397" to="1400" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Patient empowerment for cancer patients through a novel ICT infrastructure</title>
		<author>
			<persName><forename type="first">H</forename><surname>Kondylakis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">JBI</title>
		<imprint>
			<biblScope unit="volume">101</biblScope>
			<biblScope unit="page">103342</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">X3ML Framework: An Effective Suite for Supporting Data Mappings</title>
		<author>
			<persName><forename type="first">N</forename><surname>Minadakis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">EMF-CRM@ TPDL</title>
				<imprint>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Ontology evolution: assisting query migration</title>
		<author>
			<persName><forename type="first">H</forename><surname>Kondylakis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Plexousakis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">ER</title>
		<imprint>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">A Framework for eHealth Interoperability Management</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Katehakis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Strategic Innovation and Sustainability</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="51" to="61" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">A Mobile App Architecture for Accessing EMRs Using XDS and FHIR</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Petrakis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BIBE</title>
		<imprint>
			<biblScope unit="page" from="278" to="283" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<monogr>
		<ptr target="http://build.fhir.org/ig/hl7ch/covid-19-prom/branches/master/ValueSet-covid-19-prom.html" />
		<title level="m">ValueSet Covid19 Patient Reported Outcome Observations</title>
				<imprint>
			<date type="published" when="2020-09">September 2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Semantically-enabled Personal Medical Information Recommender</title>
		<author>
			<persName><forename type="first">H</forename><surname>Kondylakis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">International Semantic Web Conference</title>
				<imprint>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Multidimensional Group Recommendations in the Health Domain</title>
		<author>
			<persName><forename type="first">M</forename><surname>Stratigi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kondylakis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Stefanidis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Algorithms</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page">54</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">mHealth and telemedicine apps: in search of a common regulation</title>
		<author>
			<persName><forename type="first">C</forename><surname>Crico</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">ecancermedicalscience</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Donor&apos;s support tool: Enabling informed secondary use of patient&apos;s biomaterial and personal data</title>
		<author>
			<persName><forename type="first">H</forename><surname>Kondylakis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">IJMI</title>
		<imprint>
			<biblScope unit="volume">97</biblScope>
			<biblScope unit="page" from="282" to="292" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
